Table 1.
Standard Parameters | Tetracaine (τC↑) | Flecainide (τO↓) | Dual Mechanism (τC↑ and τO↓) | |
---|---|---|---|---|
Corresponding figure | Fig. 12A | Fig. 12B | Fig. 12C | Fig. 12D |
kco, μM−2·s−1 | 4.5 | 0.5 | 4.5 | 1.5 |
koc, s−1 | 500 | 500 | 4,500 | 1,500 |
Fraction of open channels | 9.6 × 10−4 | 2.0 × 10−4 | * | * |
Score | 0.51 | 0.59 | * | * |
Sarcoplasmic reticulum [Ca2+], μM | 342 | 1112 | * | * |
Duration, ms | 18.2 | 26.7 | 2.97 | 8.90 |
Frequency, sparks/s | 0.043 | 6.5 × 10−4 | 0.053 | 0.0059 |
Shown are results for the whole cell model with standard parameters and modified Ca2+ activation rate constant (kco), which represents the application of tetracaine and led to an increase in ryanodine receptor (RyR) open time (cf. solid and open circles in Fig. 3, respectively). When the same level of RyR inhibition was modeled as a decrease in open dwell time (τO↓), as may occur upon the application of flecainide, or a dual mechanism (τC↑ and τO↓), the mean spark duration changed.
Results identical to the tetracaine case.